Community Compass is going through a redesign tentatively scheduled to complete in Summer 2022. While all issues of HVTN Community Compass prior to 2021 are available in print at our research clinics, and online in PDF and web-layout mode; beginning 2021 and until the redesign is complete the web-layout mode will not be available. HVTN Community Compass will continue to be available in print at our research clinics and online in PDF during this time.

We look forward to welcoming you to the new website once it is launched. It will include a new look and feel to the website overall, and new ways to engage us and engage HVTN Community Compass.

Letter From The Editor

Stephaun E. Wallace, PhD, Editor-in-Chief
Stephaun E. Wallace, PhD, Editor-in-Chief

Welcome to the latest edition of the HIV Vaccine Trials Network (HVTN) Community Compass.

In this issue, we announce an award received by our very own Dr. Larry Corey, provide an update on the status of the Mosaico Study, introduce some of the former RAMP Scholars, provide an introduction to the new HVTN Faith Initiative (version 2.0), share activities from some of our sites and members and a new published article on community engagement, welcome new HVTN Core staff members and a special announcement of a promotion! While our efforts in the COVID-19 space continue, one of the global phase 3 HIV vaccine studies we are collaborating on completed enrollment, and we are expecting to see many phase 1 HIV vaccine and antibody studies begin in the coming year.

The HVTN, including our partners and communities, played a monumental role in the response to COVID-19 through the work of the COVID-19 Prevention Network. We have, and continue to see, an unprecedented level of innovation in science and clinical trials, meaningful and cross-cutting engagement of communities and stakeholders, and resource allocation to support prevention and treatment options for COVID-19, as well as testing and other services. Though this pandemic has caused death and destruction, I also recognize the countless numbers of lives that have been saved through our collective efforts. It is truly historic and noteworthy, and a moment in which we can all take pride.

While these efforts continue, our HIV efforts remain a key priority for the Network and our communities. Many people continue to wonder about the timeline for an HIV vaccine. There are many studies underway, most of which are early phase studies that are primarily looking at safety in smaller numbers of people; however, we do have one large scale HIV vaccine study in the field, Mosaico (, and we are looking forward to seeing results in the future. This study uses a mosaic-based platform which supports the evaluation of the vaccine across various types of HIV found around the world.

COVID-19 restrictions are shifting, and many communities around the world are starting to open back up. While this is occurring, conversations about the important lessons learned during the COVID-19 pandemic that can be applied to HIV continue. While we wrestle with getting COVID-19 under control, we must not ignore the continued impact of HIV in our communities globally, and the determinants of health that negatively impact the health of communities and people that make HIV acquisition and transmission more likely.

Please help us ensure that this publication is representative of our entire global HVTN community! HVTN members (who have access to the HVTN member's website) can use our submission page that offers the ability to submit content and articles for inclusion in future issues. More information about this follows on the "Meet the Community Compass Team" section.

Thank you for your continued support of the HVTN wherever you are in the world, for the work that you do in whatever role you have in the HVTN community, and for the impact we have been able to make in our collective history and communities, together. Though we have come very far in response to the HIV epidemic, we have so much further to go to achieve a globally effective HIV vaccine. The HVTN Community Compass team wants to be everywhere you are, so please share with us what's happening at your research sites, institutions, and in your communities, so that we can share it with the world.

Be well,

Stephaun E. Wallace

Stephaun E. Wallace, PhD

Editor-in-Chief, HVTN Community Compass

Our vision is an informed HVTN community that is aware of current events and activities relating to the HVTN network and its sites, advances in the field of HIV prevention and vaccination, as well as community priorities. We work to accomplish this by providing relevant information and updates to promote awareness, understanding, and support for HIV prevention and HIV vaccines, reaching global communities invested in the response to the HIV epidemic.  

We welcome submissions of articles on any topic for publication that is relevant to the HVTN community. Submissions must be exclusive to us, and not appear in any other publication. Submissions must be 500 words or less to comply with our layout and design requirements.

We do our best to read all submissions promptly and will contact you within two weeks if we are interested in publishing your article. Due to space limitations, we may need to hold publishing your article for a future issue. To submit articles for Community Compass, please go to the HVTN Members Site homepage, click on “About”, then click “Community Compass”, then click on “Submit to Community Compass”.

Meet the Community Compass Team

Stphaun Wallace, Ph.D.

Gail Broder, MHS
Anna Altavas
Cody Shipman

Nina Feldman


Choose your language. View the current issue online in Spanish, or Portuguese. Click the link(s) below to read online now:


Visit our Past Publications section to view/download pdf versions of issues available in  English, Spanish from 2008-present (includes CAB Bulletins).